Drug Database
PT

PT-003

✓ Approved

Pediatrix Therapeutics · 未知 · 未知

什么是 PT-003?

PT-003 是一种未知,由Pediatrix Therapeutics研发。该药已获批,用于治疗相关适应症,给药途径:Unknown。

药物档案

公司Pediatrix Therapeutics
药物类别未知
给药途径Unknown
状态Approved

治疗适应症

PT-003 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Immune system disordersHypersensitivity✓ Approved

相关研究文献

PubMedWorld journal for pediatric & congenital heart surgery2026-11-18

Mechanical Atrioventricular Valve Thrombosis After Warfarin Interruption in Two Patients with Single Ventricle Physiology.

Takao Hiroyuki H, Sugiyama Koki K, Toda Koichi K, Hirano Akinori A et al.

Thrombosed mechanical atrioventricular (AV) valves are catastrophic in patients with functional single-ventricle physiology; however, anticoagulation management during intercurrent illness is not well defined. We retrospectively reviewed 2 patients with functional single-ventricle physiology who underwent mechanical AV valve replacement at our institution. Mechanical valve thrombosis with leaflet immobility was diagnosed by cinefluoroscopy or echocardiography and confirmed intraoperatively. Two patients developed thrombosed mechanical AV valves after temporary warfarin cessation for supratherapeutic PT-INR during gastroenteritis. Case 1 (hypoplastic left heart syndrome following Glenn procedure, mechanical tricuspid valve) developed single-leaflet immobility after warfarin was withheld and low-dose vitamin K2 was administered for a PT-INR of 7.1. Case 2 (right atrial isomerism, Fontan circulation, mechanical common AV valve) developed bilateral leaflet immobility despite sustained PT-INR >4.0. Operative findings confirmed fresh thrombus without pannus in both cases. Valve thrombosis may occur after warfarin interruption even when PT-INR remains therapeutic, and reliance on PT-INR alone may underestimate thrombotic risk.

PMID 43048922
阅读全文 →
PubMedSmall (Weinheim an der Bergstrasse, Germany)2026-11-18

Controlling Spin-Valley Splittings in Two-Dimensional Antiferromagnets With Bicircularly Polarized Light.

Zhu Tongshuai T, Yin Xuandi X, Fan Jiyang J, Tang Likang L

Controlling spin-valley splittings in antiferromagnets offers a promising route toward spintronic and valleytronic devices, yet it remains challenging because spin degeneracy is usually protected by PT symmetry and valley degeneracy is constrained by crystalline symmetry. Here, an optical scheme is proposed to manipulate spin-valley splittings in two-dimensional PT -symmetric antiferromagnets using bicircularly polarized light (BCPL). BCPL not only breaks PT symmetry and lifts spin degeneracy but also breaks the symmetry connecting the K and K ' valleys, thereby removing the valley degeneracy. By tuning the relative phase and helicity of BCPL, four distinct spin-valley polarized states can be selectively realized. When the photon energy approaches either the band gap or half of the band gap, resonant coupling between different Floquet sectors leads to strongly enhanced spin and valley splittings. First-principles calculations for monolayer MnPS 3 confirm the phase and helicity controlled spin-valley splittings. These results establish BCPL as a powerful optical knob for engineering spin-valley physics in antiferromagnets and provide guidance for designing light-controlled spintronic and valleytronic devices.

PMID 43046613
阅读全文 →
PubMedJournal of cosmetic dermatology2026-11-18

Prediction of Tattoo Removal Sessions With Picosecond Lasers: Development and Validation of a Novel Clinical Scale With Machine Learning Techniques.

Pedrelli Valerio V, Tauro Emanuele E, Clementoni Matteo Tretti MT, Zevini Alessandra A et al.

Accurate prediction of the number of sessions required for laser tattoo removal is essential for effective treatment planning and patient counseling. The Kirby-Desai (KD) scale, developed for Q-switched nanosecond lasers, overestimates treatment sessions when applied to modern picosecond laser technology. To develop and validate a novel predictive scoring system specifically calibrated for picosecond laser tattoo removal and to compare its predictive accuracy with the KD scale. A retrospective cohort of 545 patients treated with picosecond laser tattoo removal between 2019 and 2024 was analyzed. Tattoo characteristics were evaluated using both the KD scale and the newly developed (PT) scale, which incorporates six parameters: tattoo type, pigment density, anatomical location, ink color, scarring, and layering. Multiple regression and machine learning models were trained separately on KD- and PTbased variables. Model performance was assessed using mean absolute error (MAE), root mean square error (RMSE), and coefficient of determination (R 2) on an independent test set. Model interpretability was evaluated using SHapley Additive exPlanations (SHAP). PT-based models consistently outperformed KD-based models. The PT Ridge regression model achieved the best predictive performance (MAE = 0.58, RMSE = 0.64, R 2 = 0.73), significantly improving accuracy compared with KD-based approaches (p < 0.001). SHAP analysis identified tattoo type and pigment density as the most influential predictors. The PT scale provides a more accurate and clinically relevant prediction of treatment sessions for picosecond laser tattoo removal than the KD scale, offering a practical and reliable tool for contemporary clinical practice.

PMID 43047206
阅读全文 →
PubMedFrontiers in neurology2026-11-18

Neurotoxicity associated with ALK inhibitors in the treatment of non-small cell lung cancer: an analysis of the FAERS database.

Lin Chutong C, Tang Jizheng J, Ning Yingze Y, Qiang Guangliang G

ALK inhibitors (ALKis) have substantially improved outcomes in ALK-positive non-small cell lung cancer (NSCLC). Neurological adverse events (AEs) remain clinically relevant, but their reporting patterns and reported time-to-onset (TTO) characteristics in routine pharmacovigilance require further characterization. Neurological AE reports recorded with five ALK inhibitors (crizotinib, ceritinib, alectinib, brigatinib, and lorlatinib) were extracted from FAERS (Q1 2004-Q1 2025). Reporting disproportionality was evaluated at the preferred-term (PT) level using the reporting odds ratio (ROR), proportional reporting ratio (PRR), and Bayesian confidence propagation neural network (BCPNN). TTO analyses were restricted to reports with evaluable timing information, and exploratory subgroup analyses characterized reporting-signal patterns by age, sex, and reporter type. The final analysis included 1,473 report-level reports and 2,274 PT-level neurological AE records; one report could contain more than one PT. Lorlatinib, ceritinib, brigatinib, crizotinib, and alectinib had 29, 15, 12, 9, and 9 PTs, respectively, that met all three disproportionality criteria. Among the 1,473 reports, 577 (39.17%) had evaluable TTO information. Recorded onset times among these evaluable reports were more concentrated in the earlier period after treatment initiation, but this distribution does not estimate incidence, absolute risk, or hazard among all exposed patients. This pharmacovigilance analysis identifies drug-specific patterns of reported neurological AEs and reported TTO among ALK inhibitors. The findings support clinical awareness and hypothesis generation, but they do not establish causality or comparative clinical safety and should be evaluated in studies with exposure denominators and control of confounding.

PMID 43047343
阅读全文 →
PubMedExperimental physiology2026-11-18

Does succinic acid treatment improve metabolic health in a male murine model of early ageing?

Ives Stephen J SJ, Zaleski Kendall S KS, Slocum Cheyanne C, O'Brien Gabriel G et al.

Ageing associates with obesity, mitochondrial dysfunction, and impaired glucose homeostasis. Previously, we documented that succinic acid (SA) treatment improves mitochondrial function and adiposity; however, the effects on ageing are unknown. Therefore, we determined the effect of SA treatment on metabolic health in 19 aged male mice (Age; 16 months), randomized to receive vehicle (Veh, n = 8) or SA (n = 11) and compared to young controls (Young; 6 months) (n = 24). After 6 weeks of treatment, insulin tolerance (IT), glucose tolerance (GT), pyruvate tolerance (PT) and physical activity (PA) were assessed. Body mass (BM), epididymal white adipose tissue (EWAT) and heart mass (HM) were measured at study end. Soleus muscle and EWAT underwent mitochondrial respirometry. Mice in the Age group had higher HM and EWAT (both P < 0.001). Blood glucose levels were higher in the Age group during the PT test (25470 ± 1206 vs. 31884 ± 4348 area under the curve (AUC), P = 0.014, Young vs. Age, respectively), though GT and IT were not affected (P > 0.05). PA was ∼50% lower in the Age group (8778 ± 5774 vs. 4132 ± 1523 rev/day), though Age-SA had 48% higher PA (Age-SA 6118 ± 2203 rev/day). SA treatment did not affect BM (37.8 ± 2.7 vs. 37.7 ± 3.2 g), EWAT (1.4 ± 0.4 vs. 1.3 ± 0.4 g) or HM (0.17 ± 0.01 vs. 0.19 ± 0.04 g, Age-Veh vs. Age-SA, all P > 0.05, respectively). GT AUC differed by group (P = 0.019), with Age-SA having lower AUC (Young 47120 ± 8751 vs. Age-SA 37180 ± 5383 AUC, P < 0.018), but not IT or PT (both P > 0.22). SA reversed the age-associated reduction in complex I+II-driven respiration in adipose (P < 0.05). Ageing elevated adiposity, impaired pyruvate tolerance and reduced adipose mitochondrial function, though SA was partially restorative in mitigating these age-associated effects, warranting further study.

PMID 43045958
阅读全文 →
PubMedAnalytical chemistry2026-11-18

Defect-Engineering-Tailored Triple-Enzyme-Mimetic Heterojunction Nanozyme-Based Colorimetric Sensor Array for AI-Powered On-Site Intelligent Assay of Multiple Antibiotic Residues.

Zhang Jinwei J, Huang Liang L, Hu Jiayue J, Sun Shanxin S et al.

Maintaining high levels of multienzyme-like activities within a single nanoparticle-based sensing array to boost the efficient simultaneous on-site assay of multiple antibiotic residues at low regulatory threshold levels is critical for the "One Health" initiative, but remains an ongoing challenge. Herein, a defect-engineered Pt-CuO/Cu2O heterojunction nanozyme was rationally designed with enhanced peroxidase- (POD), oxidase- (OXD), and laccase-like (LAC) activities, in which each component performs its designated function with efficient coordination. The introduction of Pt sites and increased oxygen vacancy (OV) through defect engineering modulate the heterointerface electronic structure and optimize the d-band center, as corroborated by density functional theory calculations. Such electronic modulation enhances the adsorption energy of Pt-CuO/Cu2O towards the substrates such as H2O2 (-1.02 eV to -1.49 eV) and O2 (-0.76 eV to -1.12 eV), thus boosting its triple-enzyme-like catalytic performance concurrently. Leveraging the distinct modulatory effects of β-lactams (BLs), tetracyclines (TCs), and fluoroquinolones (FQs) on these three enzyme-like activities, a single-receptor, three-channel colorimetric sensing array was constructed. Coupled with a home-made, highly-integrated and portable device for RGB signal acquisition and machine learning-assisted classification-regression models, the array achieved accurate on-site intelligent analysis of the three types of antibiotics across 0.2 μM to 100.0 μM within only 15.0 min, with performance approaching and even exceeding the regulatory limits. Performing the on-site assay on spiked milk powder samples produced satisfactory accuracy and recoveries, which were validated against authoritative LC-MS. This work establishes a defect-engineering paradigm for maintaining triple-enzyme-mimetic activities at high catalytic levels in a single nanoparticle-based efficient sensing array, enabling the on-site sensitive and accurate discrimination of multiple antibiotic residues at low concentrations through a machine learning-assisted colorimetric sensing array, thus offering both theoretical guidance and a deployable solution for food safety monitoring of multiple antibiotic residues.

PMID 43046386
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多PT-003